Laboratory Economics features Avalon EVP, Network Solutions, Mike Snyder
From the March 2024 edition:
Avalon Healthcare Solutions (Tampa, FL) is launching the AvalonSelect Genetic Network (ASGN), which will allow health plans to outsource the management of genetic test pricing, utilization and new test evaluation to Avalon. There are more than 175,000 genetic tests currently available and 10 new genetic tests are being introduced every day, notes Avalon’s Mike Snyder, Executive Vice President, Network Solutions.
The ASGN aims to provide health plans with 10+% savings on overall genetic test spending.
Snyder says that Avalon is in the process of adding genetic testing labs to ASGN. Requirements to join the network include having at least 20% of overall test volume coming from genetic tests, including Tier I & II molecular pathology procedures, genomic sequencing procedures, multianalyte assays with algorithmic analyses (MAAAs) and proprietary lab analysis (PLA) tests. In addition, Snyder says that labs joining the network must agree to a national fee schedule for genetic tests developed by Avalon.
The benefits for labs joining ASGN include greater certainty of payment, reduced prior authorization requests, and increased volume, according to Snyder.
Avalon has also begun marketing the ASGN product to health plans. Likely candidates include the 30 health plans, covering 39 million members, that already contract with Avalon for other services. Among Avalon’s existing national and regional clients are BCBS plans from North Carolina and South Carolina, as well as HCSC- Health Care Service Corporation.
Read more at Laboratory Economics.